Passa al contenuto
Merck

Avenanthramide-C prevents amyloid formation of bovine serum albumin.

Biophysical chemistry (2020-05-16)
Maria Guadalupe Quiroz Vazquez, Dvorak Montiel Condado, Brenda Gonzalez Hernandez, Azucena Gonzalez-Horta
ABSTRACT

The misfolding of protein and its assembly into amyloid fibrils with a characteristic β-sheet-rich secondary structure, cause a lot of illnesses. Polyphenols have been extensively studied as a class of amyloid inhibitors, whose effect depends on the position and number of hydroxyl groups around the flavone backbone. In this study, we used bovine serum albumin (BSA) as an amyloid model to test the anti-amyloid effects of Avenanthramide-C (Avn-C), a molecule with a long aliphatic linker between two aromatic rings. We used spectroscopy techniques like thioflavin T fluorescence and circular dichroism, to follow the β-sheet-rich aggregates of BSA upon incubation at 68 °C. Our results demonstrated that Avn-C shows higher inhibitory effect on BSA oligomerization at micromolar concentrations, than Epigallocatechin gallate (EGCG) and Curcumin, proving for the first time, that Avn-C can serve as potential molecule in preventing protein aggregation.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Supelco
Avenanthramide C, analytical standard